| Literature DB >> 35476598 |
Vanessa Oliveira1, Ruth A Riedl2, Kristin E Claflin3, Natalia M Mathieu1, McKenzie L Ritter1, Kirthikaa Balapattabi1, Kelsey K Wackman1, John J Reho1,4, Daniel T Brozoski1, Donald A Morgan3, Huxing Cui3,5, Kamal Rahmouni3,5,6,7,8, Colin M L Burnett6, Pablo Nakagawa1,9, Curt D Sigmund1,9,10, Lisa L Morselli11, Justin L Grobe1,4,9,10,12.
Abstract
The brain renin-angiotensin system (RAS) is implicated in control of blood pressure (BP), fluid intake, and energy expenditure (EE). Angiotensin II (ANG II) within the arcuate nucleus of the hypothalamus contributes to control of resting metabolic rate (RMR) and thereby EE through its actions on Agouti-related peptide (AgRP) neurons, which also contribute to EE control by leptin. First, we determined that although leptin stimulates EE in control littermates, mice with transgenic activation of the brain RAS (sRA) exhibit increased EE and leptin has no additive effect to exaggerate EE in these mice. These findings led us to hypothesize that leptin and ANG II in the brain stimulate EE through a shared mechanism. Because AgRP signaling to the melanocortin MC4R receptor contributes to the metabolic effects of leptin, we performed a series of studies examining RMR, fluid intake, and BP responses to ANG II in mice rendered deficient for expression of MC4R via a transcriptional block (Mc4r-TB). These mice were resistant to stimulation of RMR in response to activation of the endogenous brain RAS via chronic deoxycorticosterone acetate (DOCA)-salt treatment, whereas fluid and electrolyte effects remained intact. These mice were also resistant to stimulation of RMR via acute intracerebroventricular (ICV) injection of ANG II, whereas BP responses to ICV ANG II remained intact. Collectively, these data demonstrate that the effects of ANG II within the brain to control RMR and EE are dependent on MC4R signaling, whereas fluid homeostasis and BP responses are independent of MC4R signaling.Entities:
Keywords: angiotensin; blood pressure; energy; melanocortin
Mesh:
Substances:
Year: 2022 PMID: 35476598 PMCID: PMC9131927 DOI: 10.1152/physiolgenomics.00015.2022
Source DB: PubMed Journal: Physiol Genomics ISSN: 1094-8341 Impact factor: 4.297